Tango Therapeutics Inc. (TNGX)
NASDAQ: TNGX
· Real-Time Price · USD
6.79
-0.13 (-1.88%)
At close: Aug 15, 2025, 3:59 PM
6.77
-0.29%
After-hours: Aug 15, 2025, 04:59 PM EDT
Tango Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 3.18M | 5.39M | 4.12M | 11.61M | 19.88M | 6.47M | 5.43M | 10.73M | 14.6M | 5.77M | 6.41M | 6.92M | 5.77M | 5.76M | 5.72M | 6.79M | 18.15M | 6.39M |
Cost of Revenue | 625K | n/a | n/a | n/a | 632K | 625K | 617K | 613K | 1.51M | 1.46M | 1.45M | 1.22M | 686K | 670K | 21.63M | 21.92M | 19.08M | 15M |
Gross Profit | 2.56M | 5.39M | 4.12M | 11.61M | 19.24M | 5.85M | 4.81M | 10.12M | 13.09M | 4.31M | 4.96M | 5.7M | 5.08M | 5.09M | -15.92M | -15.14M | -926K | -8.61M |
Operating Income | -40.97M | -42.53M | -40.91M | -32.88M | -29.55M | -42.26M | -35.01M | -25.63M | -23.25M | -30.29M | -30.57M | -29.92M | -25.2M | -24.99M | -21.98M | -19.57M | -4.56M | -12.08M |
Interest Income | 1.24M | 1.61M | 1.81M | 1.81M | 2.07M | 2.2M | 2.24M | 1.87M | 1.45M | 1.06M | 591K | 350K | 297K | 218K | 196K | 91K | 104K | 104K |
Pretax Income | -38.82M | -39.84M | -37.62M | -29.11M | -25.49M | -37.87M | -30.72M | -22.24M | -20.65M | -28.01M | -29.01M | -29.05M | -24.86M | -25.21M | -21.87M | -19.53M | -4.51M | -12.03M |
Net Income | -38.85M | -39.88M | -37.67M | -29.17M | -25.55M | -37.91M | -30.76M | -22.26M | -20.71M | -25.73M | -29.06M | -28.18M | -24.86M | -25.04M | -22.05M | -19.59M | -4.49M | -12.11M |
Selling & General & Admin | 11.34M | 11.48M | 11.09M | 11.22M | 10.77M | 10.66M | 9.11M | 9.21M | 9.17M | 8.01M | 7.89M | 8.1M | 7.23M | 6.81M | 6.07M | 4.43M | 3.63M | 3.47M |
Research & Development | 32.18M | 36.44M | 33.94M | 33.26M | 38.65M | 38.06M | 31.34M | 27.15M | 28.67M | 28.04M | 29.09M | 28.74M | 23.74M | 24.33M | 21.63M | 21.92M | 19.08M | 15M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 2.06M | 1.51M | 2.6M | 2.28M | 1.56M | 523K | 50K | -47K | 115K | -50K | -62K | -55K |
Operating Expenses | 43.52M | 47.92M | 45.03M | 44.48M | 49.43M | 48.73M | 40.44M | 36.36M | 37.84M | 36.05M | 36.98M | 36.84M | 30.97M | 31.14M | 27.7M | 26.36M | 22.71M | 18.47M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 44.15M | 47.92M | 45.03M | 44.48M | 49.43M | 48.73M | 40.44M | 36.36M | 37.84M | 36.05M | 36.98M | 36.84M | 30.97M | 31.14M | 27.7M | 26.36M | 22.71M | 18.47M |
Income Tax Expense | 35K | 34K | 49K | 54K | 65K | 40K | 47K | 23K | 64K | -2.28M | 51K | -873K | 3K | -171K | 177K | 62K | -21K | 74K |
Shares Outstanding (Basic) | 110.54M | 110.3M | 108.68M | 108.51M | 108.31M | 108.17M | 97.22M | 97.03M | 88.35M | 88.19M | 87.97M | 87.89M | 87.84M | 87.67M | 87.57M | 70.16M | 87.47M | 87.47M |
Shares Outstanding (Diluted) | 110.54M | 110.3M | 108.68M | 108.51M | 108.31M | 108.17M | 97.22M | 97.03M | 88.35M | 88.19M | 87.97M | 87.89M | 87.84M | 87.67M | 87.57M | 70.16M | 87.47M | 87.47M |
EPS (Basic) | -0.35 | -0.36 | -0.34 | -0.27 | -0.24 | -0.35 | -0.32 | -0.23 | -0.23 | -0.29 | -0.33 | -0.32 | -0.28 | -0.29 | -0.25 | -0.28 | -0.05 | -0.14 |
EPS (Diluted) | -0.35 | -0.36 | -0.34 | -0.27 | -0.24 | -0.35 | -0.32 | -0.23 | -0.23 | -0.29 | -0.33 | -0.32 | -0.28 | -0.29 | -0.25 | -0.28 | -0.05 | -0.14 |
EBITDA | -38.19M | -41.91M | -40.29M | -32.26M | -28.92M | -41.63M | -34.4M | -25.01M | -22.64M | -29.7M | -30M | -29.51M | -24.89M | -25.07M | -21.73M | -19.34M | -4.34M | -11.88M |
EBIT | -38.82M | -42.53M | -40.91M | -32.88M | -29.55M | -42.26M | -35.01M | -25.63M | -23.25M | -30.29M | -30.57M | -29.92M | -25.2M | -25.38M | -21.98M | -19.57M | -4.56M | -12.08M |
Depreciation & Amortization | 625K | 622K | 620K | 622K | 632K | 625K | 617K | 613K | 1.51M | 1.46M | 1.45M | 1.22M | 686K | 670K | 577K | 200K | 212K | 204K |